ArticleJournal of molecular medicine (Berlin, Germany)2026
E2F7 targets S100A2 to suppress CD8
Xianchao Chen, Jinping Li, Qiang Zou, Bo Tang, Yun Huang, Bin Liao
Abstract read
In one paragraphArticle in Journal of molecular medicine (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Xianchao ChenDepartment of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, No.25 Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan, People's Republic of China.
Jinping LiDepartment of Thoracic, Cardiovascular and Vascular Surgery, The Fourth People's Hospital of Zigong City, Zigong, 643000, Sichuan, People's Republic of China.
Qiang ZouDepartment of Thoracic, Cardiovascular and Vascular Surgery, The Fourth People's Hospital of Zigong City, Zigong, 643000, Sichuan, People's Republic of China.
Bo TangDepartment of Thoracic, Cardiovascular and Vascular Surgery, The Fourth People's Hospital of Zigong City, Zigong, 643000, Sichuan, People's Republic of China.
Yun HuangDepartment of Thoracic, Cardiovascular and Vascular Surgery, The Fourth People's Hospital of Zigong City, Zigong, 643000, Sichuan, People's Republic of China.
Bin LiaoDepartment of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, No.25 Taiping Street, Jiangyang District, Luzhou, 646000, Sichuan, People's Republic of China. liaobin70@163.com.ORCID http://orcid.org/0009-0008-6218-8543 Funding
National Natural Science Foundation Project（General Program） 82070277
6 · The paper itselfAbstract
Malignant cells within the tumor microenvironment have developed numerous strategies to resist the CD8
Indexed as
Adenocarcinoma of LungCD8-Positive T-LymphocytesChemotactic FactorsGlutamineLung NeoplasmsS100 ProteinsAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMiceTumor MicroenvironmentChemotactic FactorsGlutamineS100A2 protein, humanS100 ProteinsCD8+T cellsE2F7Glutamine metabolismLung adenocarcinomaS100A2
What OpenQuestion holds
Textmetadata
Read underepoch 390